Determinants of avoidable hospitalization for type 2 diabetes. Narrative review

被引:0
|
作者
Hoyos-Loya, Elizabeth [1 ]
Gonzalez-Robledo, Maria Cecilia [2 ]
Gutierrez, Juan Pablo [3 ]
机构
[1] Escuela Salud Publ Mexico, Cuernavaca, Morelos, Mexico
[2] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Cuernavaca, Morelos, Mexico
[3] Univ Nacl Autonoma Mexico, Ciudad Univ, Mexico City, Mexico
来源
ATENCION PRIMARIA | 2024年 / 56卷 / 11期
关键词
Type 2 diabetes mellitus; Diabetic complications; Avoidable hospitalization; Hospitalization; Conditions sensitive to ambulatory care; Health status indicators; Health services; Health systems; Social determinants of health; PRIMARY-CARE; HEALTH; COVERAGE;
D O I
10.1016/j.aprim.2024.103051
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To identify the structural and intermediate determinants associated with avoidable hospitalizations (AH) of patients with type 2 diabetes mellitus (T2DM). Design: Literature review based on narrative synthesis. Data sources: Databases: PubMed, Science Direct, and Latin American and Caribbean Literature in Health Sciences (LILACS). Study selection: Documents were selected and analyzed under a critical literature review, considering inclusion and exclusion criteria. Data extraction: Information extracted from each selected article was synthesized based on the countries' income levels and the social determinants of health framework. Results: A total of 4,166 articles were relevant, 36 were selected for review. From this selection, 21 were publications conducted in high-income countries, 14 in upper-middle-income countries, and one in lower-middle-income countries. The review identified that the coverage of health services--mainly primary health care-- and health insurance contribute to reducing the risk of AH for T2DM, while social inequalities tend to increase the risk. Conclusions: The AH due to T2DM are susceptible to reduction through policies that contribute to increasing effective access to health services (availability, insurance), since they express social inequality, occurring to a greater extent in socioeconomically vulnerable populations. This review also provides evidence of the need to expand research on this topic in middle and low-income countries. (c) 2024 Published by Elsevier Espana, a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Hypertension and peripheral neuropathy are the main determinants of total arterial compliance in type 2 diabetes.
    Nguyen, M. T.
    Cosson, E.
    Pham, I.
    Banu, I.
    Chanu, B.
    Nitenberg, A.
    Valensi, P.
    DIABETES & METABOLISM, 2010, 36 : A1 - A1
  • [22] Ethnic differences in risk and determinants of lower limb amputation in people with type 2 diabetes.
    Leggetter, S
    Chaturvedi, N
    Edmonds, M
    Fuller, J
    DIABETOLOGIA, 1999, 42 : A304 - A304
  • [23] Agents in development for type 2 diabetes.
    Jarvis B.
    Elkinson S.
    Drugs in R & D, 1999, 2 (2) : 95 - 99
  • [24] Mortality in people with Type 2 diabetes.
    Lawrenson, R
    Mulnier, H
    Raleigh, V
    DIABETOLOGIA, 2003, 46 : A77 - A77
  • [25] Insulin therapy in type 2 diabetes.
    Ametov, A
    Topchiashvili, V
    DIABETOLOGIA, 1997, 40 : 1685 - 1685
  • [26] Nephropathy in patients with type 2 diabetes.
    Remuzzi, G
    Schieppati, A
    Ruggenenti, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15): : 1145 - 1151
  • [27] Arterial hypertension and type 2 diabetes.
    Louda, F.
    Addi, H.
    Hallab, L.
    Chadli, A.
    Elghomari, H.
    Farouqi, A.
    DIABETES & METABOLISM, 2010, 36 : A53 - A54
  • [28] Cardiovascular fitness and type 2 diabetes.
    Mullooly C.
    Current Diabetes Reports, 2002, 2 (5) : 441 - 447
  • [29] Protein diet in type 2 diabetes. No
    Pelaz-Berdullas, Laura
    Luis Calle-Pascual, Alfonso
    AVANCES EN DIABETOLOGIA, 2012, 28 (01): : 27 - 31
  • [30] Glomerular ultrastructure in type 2 diabetes.
    Fioretto, P
    Mauer, M
    Barzon, I
    Dalla Vestra, M
    Bortoloso, E
    Saller, A
    Nosadini, R
    Crepaldi, G
    DIABETOLOGIA, 1999, 42 : A268 - A268